<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is an important factor determining outcome from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Identification of molecular markers useful to predict lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is urgently needed </plain></SENT>
<SENT sid="2" pm="."><plain>Our objective was to identify genes useful for characterization and prediction of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Gene expression profiles of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were determined by human U133 Plus 2.0 GeneChipÂ® in 24 CRC patients, and patients with and without lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> were compared </plain></SENT>
<SENT sid="4" pm="."><plain>We focused on the visinin-like protein-1 (VSNL-1) gene and evaluated VSNL-1 mRNA expression levels with reverse transcriptase-polymerase chain reaction and immunohistochemical methods </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemical evaluation of VSNL-1 mRNA expression was also performed in 143 other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients to determine clinicopathological significance of VSNL-1 </plain></SENT>
<SENT sid="6" pm="."><plain>Twenty-four novel discriminating genes showed expression significantly different between patients with and without lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Mean level of VSNL-1 mRNA expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was significantly higher than that in tissue without lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemical examination demonstrated immunoreactivity for VSNL-1 in cytoplasm of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>High VSNL-1 expression was significantly associated with lymphatic invasion in stage II disease (p = 0.0061) and number of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> in stage III disease (p = 0.0461) </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with high VSNL-1 expression had significantly poorer prognosis than those with low expression in stage III disease (p = 0.045) </plain></SENT>
<SENT sid="11" pm="."><plain>This study is the first to demonstrate a prognostic role for VSNL-1 at the <z:chebi fb="2" ids="33699">mRNA</z:chebi> level, suggesting the possible usefulness of VSNL-1 as a predictor of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and poor prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>